Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Aim, Ammax, Aptevo, Biodesix, Biofactura, Ceapro, Connect, Elixirgen, Emergent, Exelixis, Eyepoint, Gensight, Glycomimetics, Jasper, Kintara, Maat, Medivir, Mindmed, Ose, Prosit, Tiziana, Zucara.